Results of a 12-month, multicenter, randomized trial of everolimus with reduced-exposure cyclosporine versus MMF and standard-exposure cyclosporine in De Novo cardiac transplant recipients

被引：0
|
作者：
Lebmkuhl, H. [1 ]
Livi, U. [2 ]
Arizon, J. [3 ]
Vigano, M. [4 ]
Magelli, C. [5 ]
Boissonnat, P. [6 ]
Gerosa, G. [7 ]
Musumeci, F. [8 ]
Gandjbakhch, I. [9 ]
Vanhaecke, J. [10 ]
Hexham, J. M. [11 ]
Mange, K. C. [11 ]
机构：
[1] Deutsch Herzzentrum Berlin, Berlin, Germany
[2] Osped S Maria Misericordia, Udine, Italy
[3] Hosp Univ Reina Sofia, Cordoba, Spain
[4] Univ Pavia, IRCCS, Policlin S Matteo, I-27100 Pavia, Italy
[5] Az Osp Bologna, Policlin S Orsola, Bologna, Italy
[6] Hop Cardiol Lyon, Lyon, France
[7] Univ Padua, Azienda Osped Padova, Padua, Italy
[8] Osped S Camillo Forlanini Azienda Osped Circonval, Rome, Italy
[9] Hop La Pitie Salpetriere, Serv Chirurg Thorac & Cardiovasc, Paris, France
[10] Univ Hosp Gasthuisberg, Louvain, Belgium
[11] Novartis Pharmaceut, E Hanover, NJ USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2008年 / 27卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15
引用
下载
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [1] Everolimus with reduced-exposure cyclosporine versus MMF and standard-exposure cyclosporine in de novo cardiac transplant recipients: 12-month results from a multicenter, Randomized trial
    Arizon, Jose
    Lehmkuhl, Hans
    Livi, Ugolino
    Vigano, Mario
    Branzi, Angelo
    Almenar, Luis
    Gerosa, Gino
    Musumeci, Francesco
    Vamous, Shaida
    Maccherini, Massimo
    Hexham, Mark
    Mange, Kevin C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 211 - 211
  • [2] Everolimus and reduced-exposure cyclosporine vs mmf and standard-expsosure cyclosporine:: 12-month results in DE NOVO cardiac transplant recipients
    Livi, Ugolino
    Lehmkuhl, Hans
    Arizon, Jose
    Vigano, Mario
    Magelli, Carlo
    Boissonnat, Pascale
    Gerosa, Gino
    Musumeci, Francesco
    Gandjbakhch, Iradj
    Vanhaecke, Johan
    Abeywickrama, Kamal
    TRANSPLANT INTERNATIONAL, 2007, 20 : 93 - 94
  • [3] Everolimus with reduced-exposure cyclosporine in de novo heart transplant patients: 6-month results of a multicenter, randomized trial.
    Zuckermann, A.
    Wang, S. S.
    Keogh, A.
    Ross, H.
    Frigerio, M.
    Eisen, H.
    Bara, C.
    Laufer, G.
    Cotrufo, M.
    Lena, S.
    Sips, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 443 - 443
  • [4] Everolimus With Reduced Cyclosporine Versus MMF With Standard Cyclosporine in De Novo Heart Transplant Recipients
    Lehmkuhl, Hans B.
    Arizon, Jose
    Vigano, Mario
    Almenar, Luis
    Gerosa, Gino
    Maccherini, Massimo
    Varnous, Shaida
    Musumeci, Francesco
    Hexham, J. Mark
    Mange, Kevin C.
    Livi, Ugolino
    TRANSPLANTATION, 2009, 88 (01) : 115 - 122
  • [5] 12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients
    Tedesco-Silva, Helio, Jr.
    Vitko, Stefan
    Pascual, Julio
    Eris, Josette
    Magee, John C.
    Whelchel, John
    Civati, Giovanni
    Campbell, Scott
    Alves-Filho, Gentil
    Bourbigot, Bernard
    Garcia, Valter Duro
    Leone, John
    Esmeraldo, Ronaldo
    Rigotti, Paolo
    Cambi, Vincenzo
    Haas, Tomas
    TRANSPLANT INTERNATIONAL, 2007, 20 (01) : 27 - 36
  • [6] De novo therapy with everolimus and reduced-exposure cyclosporine following pediatric kidney transplantation: A prospective, multicenter, 12-month study
    Grushkin, Carl
    Mahan, John D.
    Mange, Kevin C.
    Hexham, J. Mark
    Ettenger, Robert
    PEDIATRIC TRANSPLANTATION, 2013, 17 (03) : 237 - 243
  • [7] Everolimus with reduced cyclosporine exposure vs. MMF and conventional cyclosporine:: Results from a study in de novo heart transplant recipients
    Lehmkuhl, H.
    Livi, U.
    Boissonnat, P.
    Arizon, J.
    Vigano, M.
    Magelli, C.
    Almenar, L.
    Abeywickrama, K. H.
    Gezabegen, Y.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S202 - S202
  • [8] Safety and Efficacy of the Early Introduction of Everolimus With Reduced-Exposure Cyclosporine A in De Novo Kidney Recipients
    Oh, Chang-Kwon
    Huh, Kyu Ha
    Ha, Jongwon
    Kim, Yeong Hoon
    Kim, Yong-Lim
    Kim, Yu Seun
    TRANSPLANTATION, 2015, 99 (01) : 180 - 186
  • [9] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED-EXPOSURE CYCLOSPORINE IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: 24-MONTH ANALYSIS FROM THE TRANSFORM STUDY
    Sommerer, Claudia
    Pinchuk, Aleksey
    Aleman, Silvina
    Vuiblet, Vincent
    Van der Giet
    Amante, Angel Joaquin
    Han, Duck Jong
    Huynh-Do, Uyen
    Ingsathit, Atiporn
    Gawai, Apurva
    Gutierrez, Maria Pilar Hernandez
    Carmellini, Mario
    TRANSPLANTATION, 2020, 104 (09) : S622 - S623
  • [10] Efficacy of everolimus with reduced-exposure cyclosporine in de novo kidney transplant patients at increased risk for efficacy events: analysis of a randomized trial
    Mario Carmellini
    Valter Garcia
    Zailong Wang
    Marcela Vergara
    Graeme Russ
    Journal of Nephrology, 2015, 28 : 633 - 639
12345